← FDA DRUG APPROVALS

FDA ANDA · ANDA077510

COLESTIPOL HYDROCHLORIDE

Sponsor: IMPAX LABS

APPLICATION
ANDA077510
TYPE
ANDA
ORIGINAL APPROVAL
2006-10-24
LATEST ACTION
2026-04-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

COLESTIPOL HYDROCHLORIDEPrescription
COLESTIPOL HYDROCHLORIDE 1GM · TABLET · ORAL

Approval history

2026-04-15Labeling · Supplement 31 · standardAP
2026-04-15Labeling · Supplement 28 · standardAP
2026-04-15Labeling · Supplement 14 · standardAP
2014-10-09Manufacturing (CMC) · Supplement 8AP
2006-10-24OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →